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ROLE OF AMBULATORY CARE UTILIZATION IN ACCOUNTING FOR 
HIGHER INPATIENT ACUTE MYOCARDIAL INFARCTION 
MORTALITY AMONG ASIAN AMERICANS  
EUN JI KIM 
ABSTRACT 
Introduction: To address a lack of population-level studies that examine the association 
between ambulatory care utilization and cardiovascular outcomes among Asian 
Americans, this study examined 1) ambulatory care utilization among different 
racial/ethnic groups and 2) the association between ambulatory care utilization and 
cardiovascular outcomes.  
Method: This was a retrospective analysis of 2009–2012 Medicare fee-for-service data. 
Primary outcomes were 1) hospitalization for angina, an ambulatory care sensitive 
condition, and 2) inpatient AMI mortality. Intermediate outcomes of interest were 
ambulatory care utilization. First, a descriptive analysis of patients’ predisposing and 
enabling factors was performed, and then bivariate association between these 
predisposing and enabling factors and ambulatory care utilization was examined. Lastly, 
using multivariate logistic regression models I estimated the association between 
ambulatory care utilization and cardiovascular outcomes, adjusting for socio-
demographic and geographical characteristics.  
Results: There were 999,999 people in the analytic sample, drawn from 21.6 million 
Medicare fee-for-service enrollees. In 2009, there were significant differences in 
racial/ethnic ambulatory care utilization. Significantly lower percentage of Asians had 
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frequent ambulatory care visits (>30 visits) and outpatient cardiology clinic visits (>30 
visits) (both p-values<0.01), after adjusting for predisposing and enabling factors. Asians 
had the highest observed inpatient mortality (15.9%) and low ambulatory utilization was 
associated with increased odds (OR=1.85 [1.11–3.08]) of inpatient AMI mortality.  
Conclusion: Among Medicare fee-for-service enrollees, Asians had fewer ambulatory 
clinic visits. Low ambulatory care utilization was associated with increased odds of AMI 
mortality. Further research is needed to understand the causal relationship between 
ambulatory care utilization and cardiovascular outcomes.  
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INTRODUCTION 
Coronary artery disease, a common underlying cause of acute myocardial 
infarction (AMI), affects 15 million adults in the US and 715,000 people have AMI 
annually1. AMI mortality has significantly decreased with advancements in care, 
standardization of AMI management, and modifications of AMI-related risk factors 2-4. 
Despite these improvements, there exist significant racial and ethnic disparities in the 
treatment and outcome of AMI5-21. Multiple prior studies of disparities have focused 
almost exclusively on non-Hispanic Blacks and Hispanics, particularly their lower rates 
of invasive cardiac interventions and worse AMI mortality. However, little is known 
about the inpatient AMI mortality of Asians residing in the US. It is important to study 
Asian Americans (including Pacific Islanders) because they make up 4.8% of the US 
population and this population has been growing faster than the overall national 
population growth rate22.  
To add to the understanding of Asian American populations, I have used State 
Inpatient Data from 15 states (Arizona, California, Colorado, Florida, Illinois, 
Massachusetts, Maryland, Nevada, New Jersey, New Mexico, New York, Oregon, 
Pennsylvania, Texas, and Virginia), which contained primary admission and discharge 
diagnosis as well as patients’ socio-demographic, clinical, and administrative 
information. The data contained about 76% of Asian Americans and found Asian 
Americans to have the highest observed and age-adjusted rates of inpatient AMI 
mortality, compared to Whites, Blacks, and Hispanics. The inpatient AMI mortality 
among adults age 65 or older was 8.35%; 10.1% for Asians, 8.3% for non-Hispanic 
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Whites, 7.9% for non-Hispanic Blacks, and 8.3% for Hispanics. I also discovered that 
Asian patients who were admitted to a hospital with a primary diagnosis of AMI had 
higher rates of cardiac comorbidities (congestive heart failure, hypertension, diabetes, 
and chronic kidney disease) compared to non-Hispanic Whites, despite Asian Americans 
in the population having relatively low prevalence of AMI-related comorbidities, 
including obesity, diabetes, smoking, and hypertension23-26. On further examination, 
racial/ethnic disparity related to inpatient AMI mortality persisted even after adjusting for 
socio-demographic characteristics, medical comorbidities, invasive cardiac procedure 
use, and socioeconomic indicators. This finding indicated a need to investigate this 
phenomenon further.  
The present study is important for several reasons. First and most importantly, 
there is a significant lack of health services research among Asian Americans although 
they comprise significant proportion of the US population and their population is 
increasing at a faster rate than the national population. Some contributing factors for lack 
of health services research among Asian Americans include a lack of national data that 
captures Asian Americans as a distinct group, or assumptions that Asians are healthy and 
the population does not have much need for improvements. For example, CDC’s 
NHANES only started to identify and oversample Asian Americans starting in 2011, and 
prior to that Asian Americans were lumped into the “Other” racial category. Another 
explanation for the lack of literature may be due to the assumption that Asian Americans 
are relatively healthier. Previous epidemiologic studies found that Asian Americans have 
a low prevalence of cardiac comorbidities23-25. The limitation of these studies is that 
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many use self-reported medical conditions; individuals not having a medical diagnosis or 
being unaware that they have these diseases could have resulted in a lower reported 
prevalence of chronic medical conditions. In another study led by me, this hypothesis was 
using NHANES, which showed Asian Americans having the highest prevalence of 
undiagnosed hypertension and diabetes among different racial/ethnic groups.  
There is a need for more healthcare utilization and outcome research among Asian 
Americans. In disparity research, many racial/ethnic disparity researchers have shifted 
from identifying areas of disparities to improving existing disparities27-29. However, due 
to the lack of population-level studies identifying health disparities among Asian 
Americans, there is less perceived public need and urgency to address health issues 
among Asian Americans. In addition, Asian Americans may have worse cardiovascular 
outcomes as demonstrated by high inpatient AMI mortality rates. In addition, limited 
literature on ambulatory care utilization has shown Asian Americans to be low 
ambulatory care utilizers30-32. Therefore, it is important to examine any association 
between racial/ethnic differences in ambulatory care utilization and cardiovascular 
outcomes. This study would help further understanding of patterns of ambulatory care 
utilization by Asian Americans and identify areas that are associated with their poor 
health outcomes with respect to AMI.  
This study was conducted to fill gaps in the health services literature by 
examining an association between ambulatory care utilization and cardiovascular 
outcomes among Asian Americans. The purposes of this study included addressing 1) a 
scarcity of literature that examines health utilization by Asian Americans and 2) limited 
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number of prior research that examines an association between ambulatory care 
utilization and inpatient AMI outcomes. By conducting this research project, I planned to 
understand patterns of ambulatory care utilization by Asian Americans and identify an 
area that is associated with poor health outcomes among Asian Americans.  
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BACKGROUND 
Previous epidemiologic studies found that Asian Americans have a relatively low 
prevalence of AMI-related comorbidities, including obesity, diabetes, smoking, and 
hypertension23-26, as well as a low national-level AMI mortality rate compared to other 
racial/ethnic groups33. However, the examination of administrative inpatient data for a 
number of major states, which together account for a majority of the Asian American 
population, indicated that Asian Americans have the highest AMI inpatient mortality 
across all racial/ethnic groups. Furthermore, Asian Americans have a higher prevalence 
of cardiac comorbidities (congestive heart failure, hypertension, diabetes, and chronic 
kidney disease) than non-Hispanic Whites. I was puzzled by the differences in the 
prevalence of cardiac comorbidities between patients admitted with a diagnosis of AMI 
and the general population. To investigate the discrepancy in the prevalence of cardiac 
comorbidities, I used the CDC’s NHANES34, a nationally representative survey, to 
examine the prevalence of undiagnosed diabetes and hypertension. This study suggested 
that the national prevalence of cardiac comorbidities among Asian Americans are under-
estimated, possibly due to Asian Americans having a higher rate of undiagnosed chronic 
conditions. Additionally, I found that, even among those with access to a routine 
outpatient care provider, the prevalence of undiagnosed hypertension and diabetes 
remained high among Asian Americans. There is evidence that this may arise from a lack 
of screening among Asian Americans35. Other possible reasons include language barriers 
or cultural attitudes about seeing a healthcare provider for preventive visits.  
 There also exist significant disparities in hospitalizations for ambulatory care 
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sensitive conditions. Studies have found that racial/ethnic minorities, African Americans 
and Hispanics having high rates of ambulatory care sensitive conditions36-38. Again, there 
is a lack of literature that examines racial/ethnic disparities in hospitalizations for 
ambulatory care sensitive conditions among Asian Americans.  
 There is evidence that ambulatory care utilization is associated with general 
health outcomes39-43. Ambulatory care utilization can be measured by examining the 
continuity and frequency of care. High continuity of care or frequent ambulatory care 
utilization is associated with improved health outcomes39,42,44,45. Continuous relationships 
with providers and frequent ambulatory clinic visits reflect sustained relationships 
between providers and patients, which are associated with increased trust and 
accumulated knowledge of the patients46. Subsequently, this allows for better medical 
management and health outcomes40,41. In another study, continuous ambulatory care was 
associated with a lower rate of emergency department utilization47. 
The review of published literature provided limited information regarding 
healthcare utilization among Asian Americans, mainly due to the scarcity of studies. 
However, the abundant literature regarding disparities in ambulatory care utilization has 
shown that there exist racial/ethnic disparities in ambulatory care utilization48. In a small 
number of studies, Asian Americans were identified to be low ambulatory care utilizers, 
including for mental health and preventive care30-32. Using NHANES, I found 
significantly lower proportions of Asians (78.9%) and Hispanics (71.6%) reported having 
a routine place for healthcare compared to Whites (87.2%) and Blacks (87.0%) 
(p<0.01)49. Also, lower percentages of Asians (67.4%) and Hispanics (60.9%) had 
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healthcare visits within the past year (p<0.01) compared to other racial/ethnic groups. 
The study found better healthcare access is associated with more healthcare utilization, 
and limited healthcare access among Asian Americans may explain why they are less 
likely to utilize ambulatory care. A limited number of studies showing disparities in 
ambulatory care utilization further underscore the importance of this proposed study, 
specifically in examining an association between ambulatory care utilization and 
cardiovascular outcomes. Currently, there is no prior study that examines an association 
between ambulatory care utilization and cardiovascular outcomes among Asian 
Americans at the population-level.  
 
Conceptual Framework 
The conceptual framework (Figure 1) for this study was derived from the Andersen and 
Donabedian models44,50. Although these frameworks were developed for different 
purposes, the meshed conceptual framework based on these models supports the study 
design. The Andersen model, a popularly used framework in health services research, 
was developed to demonstrate how predisposing factors, enabling factors, and needs 
contribute to individual health care utilization. The Donabedian model was developed to 
describe quality of care by examining components of structure, process, and outcomes.  
For this study, which examines racial/ethnic variations in healthcare utilization 
and how its utilization is associated with cardiovascular outcomes, I used parts of the 
Andersen and Donabedian models. In the first part of the study, I examined the variations 
that exist in ambulatory care utilization among different racial/ethnic groups. To address 
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variations in ambulatory care utilization from sociodemographic and geographical 
characteristics, different predisposing factors (demographic characteristics) and enabling 
factors (geographical characteristics) from the Andersen model are identified and 
adjusted in describing racial/ethnic differences in ambulatory care utilization. It is 
important to adjust for predisposing and enabling factors in describing racial/ethnic 
differences in ambulatory care utilization because these factors can influence the 
utilization. For example, ambulatory care utilization of a Medicare enrollee living in a 
rural area where the closest medical clinic is located 100 miles away will be different 
than a Medicare enrollee living in a metro area with many healthcare providers in 
proximity.  In the meshed conceptual framework, ambulatory care utilization is a process 
measure of interest in examining cardiovascular outcomes, thus subsequently I used the 
Donabedian model to link process to outcome. There is a conceptual link between how 
ambulatory care utilization affects process and the eventual outcomes of the process. 
Based on studies showing an association between ambulatory care utilization and better 
health outcomes, I believed that racial/ethnic differences in ambulatory care utilization 
partly explains disparities in cardiovascular outcomes. The relevant parts from the 
Andersen and the Donabedian frameworks can be merged to explain how factors 
associated with health services utilization (Andersen model) and how health services 
utilization is part of the process that determines healthcare outcomes (Donabedian model) 
such as AMI inpatient mortality. 
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Figure 1. Conceptual framework modified from the Donabedian and the Andersen 
model 
 
The study examined predisposing factors (mainly patients’ demographic and 
clinical characteristics) and enabling factors (based on geocoded data and geographical 
location) and assessed how they affect ambulatory care utilization among Asian 
Americans. Furthermore, I examined whether the use of ambulatory care services is 
associated with inpatient AMI mortality (as the connection between process and outcome 
suggests). The main outcomes of the study were 1) inpatient AMI mortality among those 
who are hospitalized with a primary diagnosis of AMI and 2) hospitalization for angina, 
ambulatory care sensitive condition. I also studied whether there exist any associations 
among predisposing factors and enabling factors in inpatient AMI mortality or 
hospitalization for angina. My previous research study and literature review led me to 
hypothesize that low ambulatory care utilization among Asian Americans would be 
associated with higher AMI inpatient mortality and/or hospitalization for angina.  
  
Process:
Ambulatory care 
utilization among 
different 
racial/ethnic 
groups
Outcome:
1. Inpatient AMI 
mortality
2. Hospitalization for 
angina
Predisposing factors:
- demographic: age, sex, 
race, and comorbidities
Enabling factors:
- geographical: region, 
urban versus rural, 
provider availability, 
proximity to a hospital
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METHODS 
Design Overview 
This was a secondary analysis of Medicare data from 2009–2011. The study examined 
variations in ambulatory care utilization among different racial/ethnic groups and how the 
ambulatory care utilization was associated with AMI outcomes, specifically inpatient 
AMI mortality and hospitalization for angina.  
Specific Aims and Hypothesis 
I developed the following research questions: 1) Do ambulatory care utilization 
patterns, specifically primary care and cardiology care, differ among different 
racial/ethnic groups?  and 2) Is there an association between ambulatory care utilization 
and inpatient AMI mortality or hospitalization for angina among different racial/ethnic 
groups? The first question was designed to examine variations in ambulatory care 
utilization among different racial ethnic groups. I will be looking at ambulatory care 
visits to primary care providers and cardiologists. In addition, I examined utilization of 
outpatient cardiac tests. I hypothesized that Asian Americans utilize ambulatory care less 
than other racial/ethnic groups. The second question was aimed at establishing an 
association between ambulatory care utilization and AMI outcomes, specifically inpatient 
AMI mortality and hospitalization for angina. I hypothesized that low ambulatory care 
utilization will be associated with higher AMI inpatient mortality and higher rates of 
hospitalization of angina, ambulatory care sensitive condition.  
Study Data  
This was an observational study based on administrative data from a national 
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representative sample of the Centers for Medicare and Medicaid Services (CMS) 
Medicare fee-for-service data. The Medicare data was appropriate for this study because 
it contained nationally representative estimates of patients of age 65 + and their 
comprehensive healthcare information, including ambulatory care utilization, inpatient 
stays/readmissions, use of referral, and procedures. Among those who were enrolled in 
the Medicare program on 1/1/2010, I obtained a stratified random sample (N=999,999) of 
all Medicare fee-for-service enrollees aged 65 and older who were continuously enrolled 
from January 1, 2010 to December 31, 2011 with oversampling of all racial/minorities: 
Asians, non-Hispanic Blacks and Hispanics. The data contain additional health utilization 
information from January 1, 2009 to December 31, 2009. Previous studies examining 
ambulatory care utilization among Medicare fee-for-service enrollees showed that about 
31% of enrollees had fewer than 4 ambulatory care visits and 69% had 4 or more 
ambulatory care visits47. Using the 1/1/2009–12/31/2009 data to characterize the baseline 
health status and healthcare utilization, I prospectively examined cardiovascular 
outcomes during 1/1/2010–12/31/2011. Lastly, the data contained mortality information. 
This information could be used to calculate inpatient mortality, 30-days mortality, 60 
days mortality, and even 180-days mortality, allowing to measure short-term and long-
term health outcomes. 
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Figure 2. Study period 
 
 
 
 
Study Population 
There were 47.4 million Medicare enrollees who were alive and at least 66 years 
old on January 1, 2010. To capture all of patients’ health utilization, those Medicare 
enrollees with additional health insurance were excluded. Lastly, those with a 
missing/invalid birth date, sex, race/ethnicity, or zip code were excluded. After these 
inclusion and exclusion criteria were applied, there were 21.6 million Medicare fee-for-
service enrollees in the available sample. 
The data for this study contained a nationally representative sample of 1 million 
Medicare fee-for-service enrollees from the 21.6 million Medicare fee-for-service 
enrollee cohort. This was accomplished by obtaining an equal number of stratified 
random samples from each of the 306 hospital referral regions (HRR). After dividing 
each HRR into the top 50% income (high-income cohort) versus bottom 50% income 
(low-income cohort) based on median income of the zip code, an equal number of 
individuals from each race/ethnicity were compiled from the high-income and low-
income cohorts. The data was also collected to over-sample minorities and included 
300,000 non-Hispanic Whites, 300,000 Hispanics, 300,000 non-Hispanic Blacks, and 
1/1/2011/1/2009 12/31/2011 
Baseline Follow-up Pre-baseline 
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100,000 Asians. The study sample was weighted to represent the population of national 
fee-for-service Medicare enrollees (21.6 million people).  
Race/Ethnicity 
The data categorized patients into the following race/ethnicity groups based on 
self-reported identity: Hispanics, non-Hispanic Whites, non-Hispanic Blacks, Asians, and 
Others.  
The data did not identify the national origin of Asian Americans. Asian 
Americans are comprised of diverse groups, including those who are originally from 
East, Southeast Asia, Indian subcontinent, and Pacific Islands. During my previous work 
using the Inpatient State Data, I attempted to identify national origin using geocoding, but 
this was not successful due to Asians living in clusters in urban and metro areas, and the 
lack of one group being a majority in the given geographical location.  
Primary Outcomes  
The primary outcome measures were 1) inpatient AMI mortality among those 
who were admitted with a primary diagnosis of AMI (ICD-9: 410.xx) and 2) admission 
for angina without a procedure, an ambulatory care sensitive condition during 1/1/2010–
12/31/2011. Inpatient AMI mortality is one of the Inpatient Quality Indicators measured 
by the Agency for Healthcare Research and Quality (AHRQ)51. Among AMI patients, I 
further differentiated AMI cases into non-ST-segment elevation (NSTEMI) (ICD-
9=410.7x) and ST-segment elevation MI (STEMI) (all ICD-9=410.xx excluding 410.7x). 
Hospitalization for angina without procedure is one of the 12 conditions associated with 
potentially preventable hospitalization (PHH) within the Agency for Healthcare Research 
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and Quality (AHRQ) Prevention Quality Indicators52. Hospitalization for this ambulatory 
care sensitive condition will be identified using ICD diagnosis codes and corresponding 
Current Procedural Terminology (CPT) codes to identify cardiac procedures (ICD-9 
codes: 411.1, 411.8, 413 without surgical procedures [CPT codes: 01-86.99])53.  
Because of the relatively high incidence of AMI and high mortality associated 
with AMI among the study population, the study sample should be adequate to examine 
the hypothesis. In one study looking at the prevalence of AMI among the Medicare fee-
for-service enrollees, the prevalence of AMI was 830 [95% confidence interval 827–833] 
per 100,000 person-years in 201054. My previous study using the State Inpatient Data 
found that the inpatient AMI mortality among adults age 65 or older is 8.35%; 10.1% for 
Asians, 8.3% for non-Hispanic Whites, 7.9% for non-Hispanic Blacks, and 8.3% for 
Hispanics. There will be a subgroup of patients who will have more than one 
hospitalization for AMI. In 2010, the annual observed recurrent AMI hospitalization rate 
was 8.9% [95% Confidence interval: 8.8–9.1%]54. In this study, if a Medicare enrollee 
had more than one visit for AMI, one visit was randomly selected from the study period 
(1/1/2010–12/31/2011) and that visit was used to measure the AMI mortality. Due to the 
nature of the data, it is impossible to differentiate whether an AMI event during the study 
period is a first AMI versus subsequent AMI prior to the study period. Therefore, it is 
appropriate to select one random AMI visit during the study period and use that 
hospitalization to measure AMI mortality. I expect about 10% of the AMI admissions 
during the period to be from recurrence. For the outcome of hospitalization of angina, I 
measured the number of visits, as more frequent admission for ambulatory care sensitive 
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condition implies more unnecessary hospitalizations.  
Ambulatory Care Utilization 
The primary covariate of interest is ambulatory care utilization. There are two 
components, which are ambulatory care visits and ambulatory cardiac tests. Both 
covariates were measured on the outpatient claims data from 1/1/2009 to 12/31/2009. For 
ambulatory care visits, I am interested in examining different types of ambulatory visits, 
including primary care visits, cardiology visits, and other specialty visits. Using the 
provider specialty type, I identified primary care visits as those for general practice, 
family practice, internal medicine, and geriatric medicine. Clinic visits for cardiology will 
be identified separately using the provider’s national provider identifier (NPI) and the 
type of cardiac procedure being performed.  
Previous study had identified variability in specialist availability, especially in 
rural areas55. To address such geographical variations in provider availability, I examined 
the distribution of specialists and examine whether there were variations in ambulatory 
cardiac tests based on provider availability.  
I also examined outpatient cardiac tests, including electrocardiogram, 
echocardiogram, stress testing, and percutaneous interventions. Using CPT codes, the 
following cardiac tests and procedures were identified; electrocardiography (CPT: 93000, 
93005, 93010), echocardiogram (CPT: 93303, 93304, 93306–93308), stress test (CPT: 
93351, 93320, 93321, 93325, 93016, 93018, 93350), myocardial perfusion imaging 
(CPT: 78465), and angiography (CPT: 93451–93461) (Table 1). Patients were identified 
as either having the cardiac tests or procedures done or not in an outpatient setting during 
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1/1/2009–12/31/2009. 
Table 1. Measures of ambulatory care utilization 
Ambulatory care clinic 
Primary care provider 
cardiologist 
medical provider (includes internal medicine specialties) 
all providers 
Ambulatory cardiac tests CPT codes 
electrocardiography 93000, 93005, 93010 
echocardiogram 93303, 93304, 93306–93308 
stress test 93351, 93320, 93321, 93325, 93016, 93018, 93350 
myocardial perfusion imaging 78465 
 
Covariates 
Based on previous literature, key demographic attributes, comorbidities, use of 
invasive cardiac procedures, and area-based characteristics that were associated with 
AMI mortality were identified. These covariates were categorized into predisposing 
factors and enabling factors.  
Predisposing factors, which were mainly socio-demographic variables, included 
race, gender, age, and cardiac comorbidities17,56-59. Age was categorized into three 
groups: 65–74, 75–84, and 85+. For cardiac comorbidities, I identified presence of 
cardiac conditions from the Medicare data. Medicare data compiles presence of these 
medical conditions from previous healthcare utilization. These cardiac conditions include 
atrial fibrillation, chronic kidney disease, congestive heart failure, diabetes, ischemic 
heart disease, depression, stroke/TIA, cancer, anemia, hyperlipidemia, and hypertension. 
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Enabling factors (geographical characteristics) included region, urban type, 
provider availability, and distance to a nearest hospital60. Region was defined broadly as 
Northeast, South, West, or Midwest. Because these socioeconomic factors were not 
available in the Medicare Data, I will instead use zip code-level geocoded data on urban 
type, provider availability, and distance to a nearest hospital median from the Census 
Bureau’s American Community Survey and the Area Healthcare Resource File61,62. For 
PCP availability, the groups were as top quartile>82.3 PCP/100k residents, second 
quartile=69.1–82.3 PCP/100k residents, third quartile=59.2–68.9 PCP/100k residents, 
lowest quartile<59.2 PCP/100k residents. For distance to a nearest hospital, the groups 
were defined as living less than a mile, less than 5 miles, or more than 5 miles away from 
a nearest hospital.  
Among patients who were hospitalized with AMI, I examined additional 
covariates. Receipt of invasive cardiac procedure with AMI hospitalization was 
associated with improved outcomes. Using diagnosis and procedure codes from the 
International Classification of Diseases, Ninth Revision, Clinical modification and the 
corresponding Current Procedural Terminology, I identified receipt of the invasive 
cardiac procedures, specifically coronary artery bypass surgery (CABG) and 
percutaneous coronary intervention (PCI)63. To differentiate disease severity, I used the 
Elixhauser comorbidity index to adjust for differences in disease burden64. The 
Elixhauser comorbidity index identifies 30 medical conditions based on ICD codes. It 
was developed to predict hospital resource use and inpatient mortality based on comorbid 
conditions. For this study, the Elixhauser comorbidity index will help adjust for 
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differences in healthcare utilization and AMI mortality from underlying conditions 
among those who were hospitalized with AMI. 
Statistical Analysis 
There were two parts to the thesis. All statistical analyses were conducted using SAS 
software, version 9.3 (SAS Institute Inc., Cary, NC) and Stata 14.1 (StataCorp (2016) 
Stata Statistical Software: Release 14. College Station, TX, StataCorp LP).  
Study 1: Do ambulatory care utilization patterns, specifically primary care and cardiology 
care, differ among different racial/ethnic groups?  
Hypothesis: Asian Americans have a lower rate of ambulatory care utilization 
(physician visits) compared to other racial/ethnic groups. 
This analysis was performed at the individual level and included all 999,999 
Medicare enrollees in the study cohort, with aforementioned measures of ambulatory 
visits as the outcomes. Statistical analysis was performed to provide summary statistics of 
the predisposing (demographic and clinical characteristics) and enabling (geographical 
characteristics) factors of the overall study population and different racial/ethnic 
subgroups. Next, I examined an association between different racial/ethnic groups and 
ambulatory care utilization. Lastly, I examined the association between race/ethnicity and 
ambulatory care utilization adjusting for the predisposing and enabling factors using 
multivariate linear regressions. For linear regression, the coefficients were presented with 
statistical significance. For multivariate logistic regression, odds ratio with 95% 
confidence intervals were presented; hypothesis testing of differences was based on 
analysis of variance. 
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The secondary analyses included examination of racial/ethnic differences in 
health care utilization, including outpatient clinical care and outpatient cardiovascular 
tests (electrocardiography, echocardiogram, stress test, myocardial perfusion imaging, 
and angiography). Also, I also examined differences in emergency room and short-
hospital stay.  
Study 2: Is there an association between ambulatory care utilization and inpatient AMI 
mortality among different racial/ethnic groups?  
Hypothesis: Patients with infrequent ambulatory care utilization have worse 
cardiovascular outcomes compared to patients with frequent and continuous 
ambulatory care utilization. 
First, I calculated frequency of hospitalization for angina and AMI among the 
study population and by racial/ethnic groups. For AMI, I described racial/ethnic 
differences in AMI hospitalization by type of AMI, presence of invasive cardiac 
procedure, length of inpatient stay, and Elixhauser comorbidity index.  
I then examined factors associated with AMI hospitalization among difference 
racial/ethnic groups. Among those who were hospitalized with AMI, I estimated 
observed inpatient mortality. Lastly, I conduced multivariate logistic regression to 
examine the relationship between ambulatory care utilization and AMI inpatient 
mortality, adjusting for predisposing, enabling factors, and AMI-related covariates. To 
test the above hypothesis, I estimated the relative risks using two models, the first without 
including ambulatory care utilization measures and the second including these measures. 
I hypothesized that relative odds of inpatient mortality from AMI for Asians would be 
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mitigated by inclusion of the ambulatory care utilization. In addition, I repeated this 
analysis by stratifying the enrollees based on ambulatory care utilization; I hypothesized 
that among enrollees with similar ambulatory care utilization, inpatient mortality from 
AMI would be similar between Asians and Whites. 
To address the possible effects of policy changes and advancements in 
technology, sensitivity analyses were performed to examine the difference in ambulatory 
care utilization and AMI mortality between 2010 and 2011 Medicare enrollees. Also, 
subgroup analysis of AMI mortality among patients with multiple AMI hospitalization 
was be conducted to examine whether there is a stronger association between ambulatory 
care utilization and multiple inpatient AMI hospitalization.  
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RESULTS 
Study population 
Our study population of 999,999 Medicare enrollees represented 21.6 million 
Medicare enrollees, of whom 18.5 million were White, 1.5 million were Black, 0.9 
million were Hispanic, 0.5 million were Asian, and 0.2 million were Others.  
Socio-demographic characteristics 
To understand the characteristics of the study population, I examined distribution 
of gender, age, and region. There were significant differences in socio-demographic 
characteristics among different racial groups (Table 2). Overall, there were more females 
(58.3%, weighted) than males in the study population. Blacks had the highest proportion 
of female (gender distribution: 61.7% female and 38.3% male) and Other group had the 
smallest proportion of female (gender distribution: 56.2% female and 43.8% male) 
(ANOVA; p-value<0.01). Average mean age of the study population was 76.9 years old. 
Whites had the highest mean average age of 77.1 years old and Other group had the 
youngest mean average age of 74.4%. I also examined regions, which is grouped as 
Northeast, Midwest, South, or West, and found significant variations in geographical 
locations (p-value<0.01). Of note, more than half of Asians resided in the West compared 
to only 17% of the total study population that resided in the West.  
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Table 2. Socio-demographic characteristics by race* 
  
All 
(n=999,999) 
White 
(n=306,000) 
Black 
(n=306,001) 
Hispanic 
(n=306,014) 
Asian 
(n=45,033) 
Other 
(n=36,951) 
P-value 
Gender 
Male 41.7 41.9 38.3 42.8 41.0 43.8 
<0.01 
Female 58.3 58.1 61.7 57.2 59.0 56.2 
Mean age, 
years old  
76.9 77.1 76.2 75.8 76.6 74.4 <0.01 
Age group 
65–74 44.3 43.5 48.8 49.9 45.9 57.9 
<0.01 75–84 37.4 37.6 35.4 36.6 38.0 33.4 
85+ 18.3 18.9 15.8 13.5 16.0 8.7 
Region 
Northeast 19.1 19.8 15.1 15.2 16.3 15.6 
<0.01 
Midwest 24.2 25.8 19.7 8.9 9.1 15.8 
South 39.8 38.9 58.5 41.2 19.0 29.7 
West 16.9 15.6 6.7 34.8 55.6 38.8 
* weighted percentages 
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Clinical characteristics 
Next, I examined prevalence of cardiac comorbidities among different racial 
groups (Table 3). Certain medical conditions predispose patients to a higher risk of 
developing coronary artery diseases. For the analysis, the comorbidities include atrial 
fibrillation, chronic kidney disease, congestive heart failure, diabetes, ischemic heart 
disease, depression, stroke/transient ischemic attack, cancer (breast cancer, colorectal 
cancer, prostate cancer, lung cancer, endometrial cancer), anemia, hyperlipidemia, and 
hypertension.  There was a mixed finding in regards to prevalence of these medical 
conditions. Whites had significantly lower prevalence of chronic kidney disease and 
diabetes, but higher prevalence of atrial fibrillation and ischemic heart diseases 
(ANOVA; p-value<0.01). Asians had low prevalence of atrial fibrillation, chronic kidney 
diseases, congestive heart failure, ischemic heart diseases, depression, and cancer. 
However, Asians had the highest prevalence of hyperlipidemia compared to other racial 
groups (ANOVA; p-value<0.01). Blacks had the highest prevalence of diabetes, chronic 
kidney diseases, congestive heart failure, hypertension, anemia, and stroke/TIA.  
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Table 3. Prevalence of cardiac comorbidities by race* (as of 12/31/2009) 
  
All 
(n=999,999) 
White 
(n=306,000) 
Black 
(n=306,001) 
Hispanic 
(n=306,014) 
Asian 
(n=45,033) 
Other 
(n=36,951) 
P-value 
Atrial fibrillation 9.0 9.7** 4.5 4.9 4.9 5.1 <0.01 
Chronic kidney disease 12.7 12.1 19.6** 14.0 11.9 12.5 <0.01 
Congestive heart failure 16.2 15.9 20.7** 17.4 12.6 13.6 <0.01 
Diabetes 27.1 25.1 40.4** 39.7 35.3 34.7 <0.01 
Ischemic heart disease 33.4 33.7 31.6 34.8** 29.3 29.3 <0.01 
Depression 10.7 11.0 8.1 12.4** 5.4 8.6 <0.01 
Stroke/TIA 4.2 4.0 6.0** 4.3 3.5 3.4 <0.01 
Cancer 8.4 9.4 10.0** 6.5 5.8 7.2 <0.01 
Anemia 23.9 23.0 31.7** 28.7 27.2 21.4 <0.01 
Hyperlipidemia 48.8 49.1 45.1 48.1 51.9** 43.9 <0.01 
Hypertension 61.2 60.2 73.0** 62.1 62.8 57.9 <0.01 
* Weighted percentages 
** Racial/ethnic group with the highest prevalence of given cardiac comorbidity 
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Geographical characteristics  
There are variations in geographical characteristics among different racial groups 
(Table 4). I examined county-level information on urbanity, physician availability and 
proximity to a nearest hospital. These variables were selected as markers for access to 
healthcare. In terms of geographical location, highest proportions of Asians (96.1%) 
resided in metropolitan areas and only 0.8% of Asians resided in rural areas. Overall, the 
majority (77.5%) of Medicare enrollees resided in large metro. Asians also resided in 
areas where there are high number of physicians (224 physicians per 100k population) 
and Hispanics resided in areas with lowest number of physicians (198 physicians per 
100k population). Consistent with physician (any type of physicians) availability, Asians 
resided in areas with the highest number of primary care physicians (81.0 primary care 
physicians/100k population) and Hispanics resided in areas with the lowest number of 
primary care physician (70.9 primary care physicians/100k population. Last of all, I 
examined proximity to a nearest hospital. The Asians had the highest percentages 
(38.9%) residing within 1 mile of a hospital. Higher percentages of Whites (42.3%) and 
Others (45.5%) of Others resided more than 5 miles from a hospital.  
 
  
  
2
6
 
Table 4. Geographical characteristics* 
  
All 
(n=999,999) 
White 
(n=306,000) 
Black 
(n=306,001) 
Hispanic 
(n=306,014) 
Asian 
(n=45,033) 
Other 
(n=36,951) 
P-value 
Urban type 
Metropolitan 77.5 75.9 84.9 89.7 96.1 70.3 
<0.01 Urban area 12.4 13.3 7.8 6.7 3.1 15.3 
Rural 10.1 10.8 7.3 3.6 0.8 14.4 
Physician availability 
# of physicians/100k, average 208 207 216 198 224 217 <0.01** 
# of primary care 
physician/100k, average 
74.5 74.3 76.3 70.9 81 81.2 <0.01** 
Proximity to a nearest hospital 
% living <1 mile from a hospital 24.2 22.6 32.8 35.6 38.9 24.1 
<0.01 % living <5 mile from a hospital 35.4 35.2 38.8 33.3 41.2 30.6 
% living >5 mile from a hospital 40.4 42.3 28.4 31.1 19.8 45.4 
* weighted percentages 
** Comparing Asians versus non-Asians (combined Whites, Blacks, Hispanics, and Others) 
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Healthcare utilization 
Ambulatory clinic visits 
During the period of 1/1/2009–12/31/2009, there were significant differences in 
racial/ethnic ambulatory care utilization among Medicare enrollees. Overall, 31.9% of the 
overall study population had 0 ambulatory care visits, 10.6% had 1–3 ambulatory care 
visits, 14.3% had 4–6 ambulatory care visits, 21.7% had 7–12 visits, 16.7% had 13–24 
visits, and 4.9% had more than 24 ambulatory care visits. The average number of 
ambulatory care visits was 6.87, with Whites having the highest mean average of 7.35 
visits and Asians having the lowest mean average of 5.56 visits. The highest percentages 
(48.1%) of Asians had no ambulatory care visits. Besides Asians, high percentages of 
Hispanics also had zero ambulatory visits.  
Emergency room visits 
In 2009, 30.6% of the Medicare enrollees went to emergency room. There were 
significant variations in emergency room visits. Highest percentage of Blacks (37.1%) 
went to emergency room versus smallest percentages of Asians (21.4%) went to 
emergency room (ANOVA; p<0.01).  
Short-stay hospitalization  
Next, I examined short-stay hospitalization. A majority (82.2%) of Medicare 
enrollees were not hospitalized. Overall, 11.8% had one short-stay hospitalization, 5.7% 
who had 2–5 short-stay hospitalizations, and 0.2% who had six or more short-stay 
hospitalizations. Again, smallest percentages (12.8%) of Asians had any short-stay 
hospitalization and largest percentages (10.3%) of Blacks had any hospitalization 
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(ANOVA; p-value<0.01). Asians were the group with the lowest utilization of the 
emergency room, and the highest prevalence of having had no hospitalizations.  They 
were also the group with the lowest prevalence of hospital stays in any of the short-stay 
frequency categories.   
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Table 5. Healthcare utilization during 1/1/2009–12/31/2009 
  
All 
(n=999,999) 
White 
(n=306,000) 
Black 
(n=306,001) 
Hispanic 
(n=306,014) Asian (n=45,033) 
Other 
(n=36,951) 
P-value 
Number of ambulatory clinic visits (weighted percentages) 
0 31.9 30.6 35.7 41.3 48.1 33.9 
<0.01 
1–3 10.6 10.8 10.5 8.5 8.0 10.8 
4–6 14.3 14.6 13.8 10.9 10.3 12.9 
7–12 21.7 22.1 20.6 18 16 19.8 
13–24 16.7 16.9 15.1 16.1 13.3 16.7 
25+ 4.9 4.9 4.2 5.3 4.3 5.9 
Quartiles, Medians, and Means 
Q1 0 0 0 0 0 0 
  
Median 4 5 4 4 3 4 
Q3 11 11 10 11 9 10 
Mean 6.87 7.35 6.73 6.70 5.56 6.96 <0.01 
% with any emergency 
room visits 
30.6 30.3 37.1 31 21.4 25.9 <0.01 
% with any short-stay hospitalization 
0 82.2 82.3 79.7 82.4 87.2 84.8 
<0.01 
1 11.8 11.9 12.3 11.3 9.0 9.9 
2–5 5.7 5.6 7.5 5.9 3.7 5.1 
6 or more 0.2 0.2 0.6 0.4 0.1 0.3 
* Weighted percentages 
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Coefficients of predisposing and enabling factors in ambulatory care utilization 
Because ambulatory care utilization is determined by both predisposing and 
enabling factors, I examined linear regression with both predisposing and enabling 
factors (Table 6). Compared to Whites, minority groups had smaller coefficient for 
number of ambulatory care visits, with Asians having the fewest visits compared to 
Whites (Black=-1.30, Hispanic=-0.76, and Asian=-1.62 fewer visits). Interestingly, when 
adjusted for both predisposing and enabling factors, elders (age group 85+) had decreased 
ambulatory care utilization compared to age group 65–74 (coefficient=-1.59). Being a 
female (coefficient=0.94) and presence of any comorbidities (atrial fibrillation, chronic 
kidney disease, congestive heart failure, diabetes, ischemic heart disease, depression, 
stroke/TIA, cancer, anemia, hyperlipidemia, and hypertension) were associated with 
more visits. Using South as reference, those who reside in West region had increased use 
of ambulatory care (coefficient=0.34). Overall, those residing in metropolitan areas had 
higher ambulatory care utilization (coefficient=0.29) compared to rural areas. Compared 
to areas with lowest PCP availability, all other groups had small but increased in 
ambulatory care visits: top quartile (coefficient=0.43), second quartile (coefficient=0.26), 
and (third quartile coefficient=0.13). Proximity to a hospital was associated with 
increased ambulatory care utilization. Compared to those who live 5 miles or further from 
a nearest hospital, those who live within 1 mile of a hospital (coefficient=0.19).  
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Table 6. Coefficients of enabling and predisposing factors for ambulatory care 
utilizations during 1/1/2009–12/31/2009 
Enabling and predisposing factors Coefficient 
Race 
Black -1.30 
Hispanic -0.76 
Asian -1.62 
Other 0.44 
Age group 
75–84 0.10 
85+ -1.59 
Gender 
Female 0.94 
Cardiac comorbidities 
Atrial fibrillation 4.52 
Chronic kidney disease 2.17 
Congestive heart failure 1.09 
Diabetes 0.48 
Ischemic heart disease 1.91 
Depression 1.84 
Stroke/TIA 0.95 
Cancer 4.65 
Anemia 2.62 
Hyperlipidemia 1.79 
Hypertension 2.18 
Region 
Northeast 0.01* 
Midwest -0.04* 
West 0.34 
Urban type 
Metro 0.29 
Suburban 0.28 
PCP availability** 
Top quartile 0.43 
Second quartile 0.26 
Third quartile 0.13 
Distance to nearest hospital 
Living <1 mile from a hospital 0.19 
Living <5 mile from a hospital 0.07* 
* Reference group: White, age group 65–74, and male, region-South, urban type-rural, PCP 
availability-lowest quartile, distance to nearest hospital-living >5 miles away from a hospital 
** PCP availability: top quartile>82.3 PCP/100k residents, second quartile=69.1–82.3 PCP/100k 
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residents, third quartile=59.2–68.9 PCP/100k residents, lowest quartile<59.2 PCP/100k residents 
 
Ambulatory cardiac test utilization 
I examined the utilization of ambulatory cardiac tests as identified through CPT 
codes. For this study, ambulatory cardiac tests of interest include electrocardiogram 
(EKG), echocardiogram (ECHO), stress test, and myocardial perfusion imaging (Table 
7). Depending on types of cardiac tests, there were different prevalence in obtaining these 
tests (all p-values<0.01). EKG was most commonly done, with 44.7% of study 
population getting at least one EKG performed in 2009. The next frequently conducted 
cardiac tests included stress test (11.4%) and myocardial perfusion imaging (9.4%), and 
then echocardiogram (2.7%). Among different racial/ethnic groups, there were significant 
variations in obtaining cardiac tests. Highest percentages of Blacks had 
electrocardiogram, but for other cardiac tests (echocardiogram, stress test, and 
myocardial perfusion imaging), highest percentages of Hispanics had them done. 
Smallest percentages of Asians had a myocardial perfusion imaging, but for other tests, 
their prevalence was neither the highest nor lowest.  
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Table 7. Percentages of patients with cardiac imaging test during 1/1/2009–12/31/2009* 
  
All 
(n=999,999) 
White 
(n=306,000) 
Black 
(n=306,001) 
Hispanic 
(n=306,014) 
Asian 
(n=45,033) 
Other 
(n=36,951) 
P-
value 
Electrocardiogram 44.7 44.8 45.1 43.3 41.9 37.4 <0.01 
Echocardiogram 2.7 2.6 3.2 3.5 3.3 2.5 <0.01 
Stress test 11.4 11.5 10.4 11.7 11.6 10.7 <0.01 
Myocardial perfusion imaging 9.4 9.4 9 9.8 8.2 8.6 <0.01 
* weighted percentages 
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Predictors of getting ambulatory cardiac tests 
Adjusting for both predisposing and enabling factors, I conducted multivariate 
logistic regressions to identify predictors for ambulatory cardiac tests (Table 8). There 
were statistically significant differences in likelihood of getting ambulatory cardiac tests. 
Minorities (Black OR=0.86 [0.85–0.88], Hispanic OR=0.88 [0.86–0.89], Asian OR=0.90 
[0.86–0.94], Other OR=0.83 [0.79–0.87]) were less likely to get ECHO compared to 
Whites. This finding was persistent in stress test (Black OR=0.88 [0.86–0.91], Hispanic 
OR=0.92 [0.89–0.94]) and myocardial perfusion imaging test (Black OR=0.93 [0.90–
0.96], Hispanic OR=0.97 [0.94–1.00]). For echocardiogram, minorities (Black OR=1.16 
[1.10–1.23], Hispanic OR=1.22 [1.16–1.28], and Asian OR=1.16 [1.01–1.33]) were more 
likely to have the test performed than Whites. 
I also examined other predictors of getting ambulatory cardiac tests. Older 
patients were less likely to get ambulatory cardiac tests. For example, those who are 75 to 
84 years old were 19% less odds (OR=0.81 [0.79–0.84]) of getting stress test and those 
who are 85 years or older were 0.63% less odds (OR=0.37 [0.36–0.39] compared to those 
ages 65–74. Cardiac comorbidities, such as presence of atrial fibrillation, congestive heart 
failure, history of ischemic heart disease, cancer, anemia, hyperlipidemia, and 
hypertension, were associated with increased odds of getting ambulatory cardiac tests. 
There were regional variations in obtaining cardiac tests, but there were no consistent 
patterns. This finding also persisted for urban type, primary care availability, and distance 
to the nearest hospital.  
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Table 8. Odds ratio of having cardiac tests during 1/1/2009–12/31/2009 
Cardiac tests 
  
EKG ECHO Stress 
Myocardial perfusion 
imaging 
Race 
Black 0.86 [0.85–0.88] 1.16 [1.10–1.23] 0.88 [0.86–0.91] 0.93 [0.90–0.96] 
Hispanic 0.88 [0.86–0.89] 1.22 [1.16–1.28] 0.92 [0.89–0.94] 0.97 [0.94–1.00] 
Asian 0.90 [0.86–0.94] 1.16 [1.01–1.33] 1.02 [0.95–1.09] 0.93 [0.86–1.01] 
Other 0.83 [0.79–0.87] 0.94 [0.81–1.09] 0.96 [0.90–1.09] 0.99 [0.91–1.07] 
Age group 
75–84 1.03 [1.01–1.05] 0.85 [0.80–0.91] 0.81 [0.79–0.84] 0.85 [0.83–0.88] 
85+ 0.84 [0.82–0.87] 0.56 [0.51–0.61] 0.37 [0.36–0.39] 0.42 [0.40–0.44] 
Gender 
Female 1.02 [1.00–1.04] 0.95 [0.90–1.01] 0.90 [0.87–0.93] 0.93 [0.90–0.96] 
Cardiac comorbidities 
Atrial fibrillation 2.86 [2.74–2.98] 1.91 [1.77–2.06] 1.15 [1.38–1.52] 1.46 [1.39–1.54] 
Chronic kidney disease 1.23 [1.19–1.27] 1.10 [1.02–1.18] 0.95[ 0.91–0.99] 0.96 [0.92–1.01] 
Congestive heart failure 1.53 [1.48–1.58] 1.80 [1.68–1.92] 1.00 [0.97–1.05] 1.02 [0.98–1.06] 
Diabetes 0.92 [0.90–0.94] 0.94 [0.88–1.00] 0.94 [0.91–0.97] 1.00 [0.96–1.03] 
Ischemic heart disease 2.54 [2.49–2.60] 2.29 [2.14–2.46] 5.31 [5.13–5.50] 5.85 [5.63–6.09] 
Depression 1.46 [1.42–1.51] 1.00 [0.93–1.09] 0.96 [0.91–1.00] 0.97 [0.92–1.01] 
Stroke/TIA 2.18 [2.07–2.30] 1.81 [1.65–1.98] 0.97 [0.91–1.04] 0.96 [0.90–1.03] 
Cancer 1.62 [1.56–1.68] 1.10 [1.00–1.20] 1.13 [1.07–1.18] 1.11 [1.05–1.17] 
Anemia 1.80 [1.76–1.84] 1.41 [1.33–1.51] 1.13 [1.09–1.17] 1.12 [1.08–1.16] 
Hyperlipidemia 1.58 [1.55–1.62] 1.49 [1.40–1.59] 2.03 [1.96–2.10] 2.04 [1.96–2.11] 
Hypertension 2.10 [2.05–2.14] 1.56 [1.44–1.70] 1.64 [1.57–1.71] 1.72 [1.64–1.80] 
Region 
Northeast 1.23 [1.19–1.26] 1.44 [1.33–1.56] 0.92 [0.88–0.97] 0.87 [0.83–0.92] 
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Midwest 0.79 [0.77–0.81] 1.08 [1.00–1.16] 0.94 [0.91–0.98] 0.90 [0.86–0.93] 
West 0.83 [0.81–0.85] 1.56 [1.45–1.68] 1.08 [1.03–1.12] 0.87 [0.83–0.91] 
Urban type 
Metro 1.31 [1.27–1.35] 0.93 [0.86–1.02] 1.26 [1.20–1.33] 1.22 [1.12–1.29] 
Suburban 1.03 [0.99–1.07] 0.98 [0.88–1.09] 1.04 [0.98–1.10] 1.04 [0.97–1.11] 
PCP availability** 
top quartile 1.12 [1.08–1.15] 1.15 [1.06–1.24] 0.96 [0.92–1.00] 0.91 [0.87–0.95] 
second quartile 1.08 [1.05–1.11] 1.00 [0.92–1.08] 0.98 [0.94–1.02] 0.96 [0.91–1.00] 
third quartile 1.05 [1.02–1.08] 1.09 [1.01–1.19] 1.00 [0.96–1.04] 0.99 [0.94–1.03] 
Distance to nearest hospital 
Living <1 mile from a hospital 1.11 [1.08–1.14] 1.15 [1.08–1.24] 0.99 [0.95–1.02] 0.94 [0.90–0.98] 
Living <5 mile from a hospital 1.07 [1.05–1.10] 1.06 [1.00–1.13] 0.99 [0.95–1.02] 0.97 [0.94–1.01] 
* Reference group: White, age group 65–74, and male, region-South, urban type-rural, PCP availability-lowest quartile, 
distance to nearest hospital-living >5 miles away from a hospital 
** PCP availability:  top quartile>82.3 PCP/100k residents, second quartile=69.1–82.3 PCP/100k residents, third quartile=59.2–
68.9 PCP/100k residents, lowest quartile<59.2 PCP/100k residents 
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Hospitalization for angina 
Next, I examined prevalence of hospitalization for angina, an ambulatory care 
sensitive conditions during 1/1/2010–12/31/2011 (Figure 3). Overall and racial/ethnic 
specific prevalence of hospitalization for angina was about small (prevalence was less 
than 0.1%). Because the prevalence of hospitalization for angina was very small, further 
analysis in determining factors associated with hospitalization for angina was not 
investigated.  
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Figure 3. Rate (%) of hospitalization for angina in 
2009
  38
Hospitalization for AMI 
Among the Medicare enrollee population, prevalence of AMI hospitalization was 
1.5% (Table 9). Asian Americans had the lowest rate of hospitalization during the study 
period (hospitalization rate for AMI=1.0%). Further descriptive analysis of the AMI 
hospitalization showed that there were variations in types of AMI, prevalence of invasive 
cardiac procedures, and length of hospital stay. Highest percentages of Asians had 
STEMI (32.3%) compared to White (31.4%), Black (23.8%), Hispanic (26.4%), and 
Other (26.5%). Among those who were hospitalized for AMI, highest percentages of 
White (34.2%) received percutaneous coronary intervention. For coronary artery bypass 
graft, highest percentage of Hispanics (6.5%) had the procedure, but this was not 
statistically significant. Highest percentage of Asians had long hospital stay (8 days or 
more) and higher percentages of White had short hospital stay (1–3 days).  
Table 9. Prevalence of hospitalization for AMI and their characteristics (during 1/1/2010–
12/31/2011) 
  All White Black Hispanic Asian Other P-value 
% with hospitalization  1.50 1.52 1.50 1.46 1.01 1.17 <0.01 
# of people with AMI 
hospitalization 
14,466 4,622 4,535 4,334 492 483   
Type of AMI 
NSTEMI 69.4 68.6 76.2 73.6 67.7 73.5 
<0.01 
STEMI 30.6 31.4 23.8 26.4 32.3 26.5 
Prevalence of invasive cardiac procedures 
PCI 33.5 34.2 25.6 31.7 27.9 46.0 <0.01 
CABG 5.5 5.5 4.9 6.5 5.1 3.6 0.30 
Length of stay (day) 
1 12.6 12.9 10.5 10.2 10.3 12.4 
<0.01 
2–3 32.3 32.9 26.7 29.9 29.8 31.1 
4–7 33.7 33.3 38.1 34.6 33.6 34.0 
8+ 21.5 21.0 24.7 25.3 26.3 22.5 
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Presence of comorbid conditions among patients with AMI hospitalization 
Next, I examined clinical characteristics of the patients with AMI hospitalization.  
Whites had the highest prevalence of cardiac arrhythmias, pulmonary circulation 
disorder, hypertension, hypothyroidism, rheumatoid arthritis/collagen vascular disease, 
and depression. Blacks had the highest prevalence of congestive heart failure, 
neurological disorder, metastatic cancer, and weight loss. Hispanics had the highest 
prevalence of hypertension and liver disease. Lastly, Asians had the highest prevalence of 
diabetes with chronic complications, renal failure, coagulopathy, and fluid and electrolyte 
disorder. 
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Table 10. Prevalence (weighted %) of Elixhauser comorbidities among patients with AMI hospitalization (during 1/1/2010–12/31/2011) 
  
All 
(n=14,466) 
White 
(n=4,622) 
Black 
(n=4,535) 
Hispanic 
(n=4,334) 
Asian 
(n=492) 
Other 
(n=483) 
P-value 
Congestive heart failure 39.4 39 43.6 42.6 38.2 42.6 0.03 
Cardiac arrhythmias 28.3 29.4 22 22 19.8 19.9 <0.01 
Valvular disease 14.8 15.1 13.4 12.5 12.4 10.3 0.04 
Pulmonary circulation disorders 5.0 4.9 7.0 4.6 2.2 6.6 <0.01 
Hypertension 47.8 48.4 41.7 47.1 41.8 45.8 <0.01 
Paralysis 0.7 0.6 1.2 0.6 0.3 0.2 0.02 
Other neurological disorders 4.2 4.0 6.0 5.2 5.4 4.2 0.04 
Diabetes, uncomplicated 27.3 26.3 33.5 37.9 28.9 30.0 <0.01 
Diabetes with chronic complications 4.1 3.7 5.6 7.2 11.2 6.9 <0.01 
Hypothyroidism 13.3 14 6.3 11.8 10.1 10.2 <0.01 
Renal failure 3.6 2.6 9.5 8.4 17.9 8.7 <0.01 
Liver disease 0.4 0.3 0.4 1.6 1.1 0.5 <0.01 
Metastatic cancer 1.1 1.0 2.0 1.0 0.1 3.7 <0.01 
RA/collagen vascular diseases 2.6 2.7 2.5 1.8 0.7 0.9 0.01 
Coagulopathy 4.4 4.2 4.6 6.0 7.7 3.4 0.10 
Weight loss 2.9 2.6 5.2 3.9 4.8 2.5 <0.01 
Fluid and electrolyte disorders 21.2 20.4 26.0 26.0 28.5 31.4 <0.01 
Deficiency anemias 14.2 13.8 16.1 18.0 15.0 20.4 0.03 
Depression 6.5 6.9 3.6 5.1 3.6 4.3 <0.01 
* Prevalence of acquired immune deficiency syndrome, lymphoma, alcohol abuse, drug use, and psychoses not shown due to low 
prevalence (<1%). Prevalence of peripheral vascular disease, chronic pulmonary disease, peptic ulcer disease without bleeding, solid 
tumor without metastasis, obesity, and blood loss anemia are not shown as there was no statistical significant difference.  
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Predictors of hospitalization with a primary diagnosis of AMI 
To understand hospitalization for AMI, I examined clinical predictors of AMI 
admissions (Table 11). After adjusting for age and gender, only Asians (OR=0.68 [0.56–
0.82]) were less like to be admitted for AMI compared to Whites. However, when cardiac 
comorbidities were adjusted, all minorities (Black OR=0.89 [0.84–0.95], Hispanic 
(OR=0.88 [0.83–0.94], Asian OR=0.66 [0.54–0.80], and Other OR=0.82 [0.68–0.99]) 
were less likely to be admitted for AMI. Lastly, I included geographical characteristics 
and minorities continued to have lower odds of being admitted for AMI.  
Being female was associated with decreased odds of getting admitted with AMI. 
Older age and presence of cardiac comorbidities (chronic kidney disease, congestive 
heart failure, diabetes, ischemic heart disease, depression, stroke/TIA, and hypertension) 
were associated with increased odds of being admitted for AMI. Presence of cancer and 
atrial fibrillation were associated with decreased odds of being admitted for AMI. There 
were no significant variations in region, urban type, PCP availability, or proximity to a 
hospital in likelihood of AMI admission.  
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Table 11. Odds ratio of hospitalization for AMI (during 1/1/2010–12/31/2011) (N=999,999) 
  
Race/ ethnicity +Gender + Age group 
+ Cardiac 
comorbidities 
+Geographical 
Characteristics 
Race/ethnicity 
White (reference) 
Black 0.99 [0.93–1.05] 1.00 [0.94–1.06] 1.05 [0.98–1.11] 0.89 [0.84–0.95] 0.91 [0.84–0.97] 
Hispanic 0.96 [0.90–1.02] 0.96 [0.90–1.01] 1.02 [0.96–1.08] 0.88 [0.83–0.94] 0.92 [0.86–0.98] 
Asian 0.66 [0.54–0.80] 0.66 [0.55–0.80] 0.68 [0.56–0.82] 0.66 [0.54–0.80] 0.69 [0.57–0.84] 
Other 0.77 [0.63–0.93] 0.76 [0.63–0.92] 0.87 [0.71–1.05] 0.82 [0.68–0.99] 0.82 [0.68–1.00] 
Gender 
Male (reference) 
Female   0.75 [0.70–0.80] 0.69 [0.64–0.74] 0.76 [0.71–0.82] 0.76 [0.71–0.82] 
Age groups 
65–74 (reference) 
75–84     1.55 [1.42–1.68] 1.33 [1.22–1.45] 1.33 [1.22–1.45] 
85+     2.57 [2.35–2.82] 2.00 [1.82–2.21] 2.00 [1.82–2.21] 
Cardiac comorbidities (1/0) 
Atrial fibrillation       0.73 [0.65–0.83] 0.73 [0.65–0.83] 
Chronic kidney disease       1.27 [1.16–1.38] 1.27 [1.16–1.39] 
Congestive heart failure       1.50 [1.38–1.64] 1.50 [1.37–1.64] 
Diabetes       1.51 [1.40–1.63] 1.51 [1.40–1.63] 
Ischemic heart disease       1.92 [1.77–2.09] 1.92 [1.77–2.09] 
Depression       1.03 [0.93–1.15] 1.03 [0.93–1.15] 
Stroke/TIA       1.25 [1.09–1.43] 1.25 [1.09–1.43] 
Cancer       0.83 [0.73–0.94] 0.83 [0.73–0.94] 
Anemia       1.06 [0.98–1.15] 1.06 [0.98–1.15] 
Hyperlipidemia       0.94 [0.87–1.02] 0.95 [0.88–1.02] 
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Hypertension       1.12 [1.02–1.23] 1.12 [1.02–1.22] 
Region 
South (reference) 
Northeast         1.08 [0.97–1.21] 
Midwest         1.02 [0.93–1.12] 
West         0.96 [0.87–1.05] 
Urban type 
Metropolitan         0.90 [0.81–1.00] 
Urban area         1.08 [0.95–1.23] 
Rural (reference) 
PCP availability 
top quartile         1.05 [0.94–1.16] 
second quartile         1.03 [0.93–1.14] 
third quartile         1.01 [0.91–1.11] 
fourth quartile (reference) 
Distance to nearest hospital 
Living <1 mile from a hospital         0.99 [0.90–1.09] 
Living <5 mile from a hospital         1.02 [0.93–1.10] 
Living ≥5 miles from a hospital (reference) 
 
  44
Inpatient AMI mortality 
There were 14,466 Medicare enrollees with AMI hospitalization from January 1, 
2010 to December 31, 2011. Overall mortality was 8.7%. There was a significant 
difference in AMI mortality (p-value<0.01). Asians had the highest observed inpatient 
mortality (15.9%) and Other had the lowest mortality (6.2%).  
 
Odds ratio of AMI mortality 
Finally, I performed sequential multivariate logistics to examine an association 
between ambulatory care utilization and inpatient AMI mortality. After adjusting for 
predisposing and enabling factors, Asians remained to have increased odds (OR=1.90 
[1.00–3.61]) of AMI mortality. This significance disappeared after adjusting for invasive 
cardiac procedures (coronary artery bypass graft and percutaneous coronary 
intervention). Lastly, ambulatory care utilization was included in the model, and Asians 
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Figure 4. Inpatient AMI Mortality (%)
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remained to have increased odds of AMI mortality (OR=1.83 [0.98–3.42]) but this was 
not significant.  
In the final model, receipt of percutaneous coronary intervention was associated 
with 43% decrease in AMI mortality, but receipt of coronary artery bypass graft was not 
associated. Compared to moderate ambulatory care utilization (4–30 ambulatory care 
clinic visits), low use of ambulatory clinic visits (0–3 visits) was associated with 85% 
decreased odds (OR=1.85 [1.11–3.08] of AMI mortality. There was no association 
between AMI mortality and frequent ambulatory care utilization (31 or more ambulatory 
clinic visits). Among different ambulatory cardiac tests, receipt of EKG was associated 
with decreased odds (OR=0.70 [0.53–0.92]) of AMI mortality. Receipt of any of the 
cardiac tests in 2009 was associated with decreased odds (0.68 [0.51–0.90] of inpatient 
AMI mortality. 
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Table 12. Odds ratio of inpatient AMI mortality (during 1/1/2010–12/31/2011) (N=14.466) 
  Race/ ethnicity 
+Predisposing 
factors 
+ Enabling 
factors 
+ Type of AMI, 
invasive cardiac 
procedures, and 
length of stay 
+Ambulatory 
care utilization 
Race/ethnicity 
White (reference) 
Black 
0.84  
[0.68–1.05] 
0.83  
[0.65–1.05] 
0.85  
[0.67–1.10] 
0.90  
[0.70–1.16] 
0.88  
[0.68–1.14] 
Hispanic 
1.09  
[0.88–1.35] 
1.09  
[0.87–1.38] 
1.15 
 [0.90–1.47] 
1.21  
[0.94–1.55] 
1.19  
[0.92–1.53] 
Asian 
1.99  
[1.07–3.70]* 
1.84  
[0.98–3.47] 
1.90  
[1.00–3.61]* 
1.91  
[1.04–3.51]* 
1.91  
[1.05–3.48]* 
Other 
0.70  
[0.38–1.26] 
0.76  
[0.41–1.41] 
0.73  
[0.39–1.36] 
0.85 
[0.46–1.60] 
0.83 
[0.44–1.57] 
Type of AMI 
NSTEMI       
0.39  
[0.29–0.52]* 
0.39  
[0.30–0.52]* 
STEMI (reference) 
Invasive cardiac procedures 
PCI       
0.49  
[0.33–0.72]* 
0.50  
[0.34–0.72]* 
CABG       
1.31 
[0.69–2.48] 
1.28 
[0.68–2.40] 
Length of stay (days) 
1 (reference) 
2–3       
0.55  
[0.38–0.79]* 
0.55  
[0.38–0.79]* 
4–7       
0.34  
[0.23–0.50]* 
0.34  
[0.23–0.50]* 
8+       
0.45  
[0.30–0.69]* 
0.46  
[0.30–0.70]* 
Ambulatory care utilization in 2009 
0–3         
1.87 
[1.11–3.16]* 
4–12 (reference) 
13+         
1.18 
[0.86–1.62] 
Ambulatory cardiac tests in 2009 
Yes         
0.73 
 [0.55–0.95]* 
No (reference) 
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DISCUSSION 
In a sample of 21.6 million Medicare enrollees, Asians had the fewest average 
number of ambulatory care visits among different racial/ethnic groups, but there was no 
consistent pattern in different types of ambulatory cardiac imaging or tests. In general, 
Asians were low healthcare utilizers; in addition to low ambulatory care clinic visits, they 
also had low emergency room visits and short-stay hospitalizations. This finding of low 
healthcare visits was also found among Asians being admitted for angina without 
procedures and acute myocardial infarction. For angina, there was a statistically 
significant difference in the hospitalization rate although the overall the rate was very 
small (0.2% or less among the study population).  
This study examined population level differences in healthcare utilization. From 
the study, it is unclear which individual level reasons were behind the low healthcare 
utilization, whether it is due to people being healthy and not needing healthcare versus 
people not utilizing healthcare although they need it. In the analysis, the presence of 
comorbid conditions was adjusted to address possible confounding effects. Still, there is 
still a possibility that a group of patients with comorbidities may not be seeking medical 
care for different reasons.  
In regards to the second objective of the study, Asian Americans had the highest 
observed inpatient AMI mortality, which is consistent with previous work65. 
Furthermore, I established an association between ambulatory care utilization and 
inpatient AMI mortality; a smaller number of ambulatory clinic visits was associated with 
increased odds of AMI mortality and the use of any ambulatory cardiac tests was 
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associated with decreased odds of AMI mortality. In multivariate logistic regression, the 
high odds ratio of inpatient AMI mortality among Asians was attenuated when receipt of 
cardiac procedures was included in the analysis. This was due to smaller percentages of 
Asians receiving invasive cardiac procedures compared to the overall study population.  
Our study established an association between ambulatory care utilization, both in 
the number of ambulatory clinic visits and ambulatory cardiac imaging tests and inpatient 
AMI mortality. It is possible that the low ambulatory care utilization may contribute to 
the high inpatient AMI mortality among Asian Americans. Previous studies have 
established an association between ambulatory utilization and health outcomes, and our 
study further supported the association between low healthcare utilization and worse 
health outcomes, specifically among Asian Americans. One limitation of the population 
level measure of low ambulatory care utilization is the question of whether low 
ambulatory care utilization reflects low healthcare utilization associated with good health 
versus low utilization due to barriers to accessing health care. This was addressed to 
some degree by examining geographical characteristics and adjusting for these factors in 
the model.  
Low ambulatory care utilization could potentially result in cardiovascular 
outcomes through several mechanisms. One possibility is that there may exist higher 
unobserved disease burden and severity among Asian Americans from the lack of such 
diagnoses. Lower ambulatory care utilization is associated with a lower rate of being 
aware of having medical diagnosis. Our study showed some evidence of this, by finding 
higher prevalence of some cardiac comorbidities contrary to epidemiologic studies23-26. 
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Also, low ambulatory care utilization may indirectly reflect Asians having difficulty 
navigating health care, thus the lower number of healthcare visits.  
Independent of healthcare utilization, another reason for poor health AMI 
outcomes among Asians may arise from higher cardiovascular risks than previously 
believed. Emerging studies have shown a subgroup of Asians having cardiovascular 
disease, specifically South Asians. In addition, studies have shown that the adoption of 
Western diet and lifestyles is association with increased cardiovascular risk. There had 
been waves of Asian immigration, peaking in 1970s and 1980s after the 1965 Act was 
passed66. As these groups of Asians adopt Western lifestyles and become more 
acculturated, their cardiovascular risks may become similar to other Americans67,68. This 
cardiovascular risk is strongly associated with the number of years they resided in the 
US69-71. 
In our study, the high number of ambulatory clinic visits was not associated with 
AMI mortality. I hypothesize that this group encompasses two groups of patients with 
different healthcare utilization behaviors; one group is composed of those with multiple 
medical conditions and another group who are healthy but high healthcare utilizers. 
These potentially different groups of people in the same category can negate the overall 
significant finding. For example, those who were making ambulatory visits may have 
multiple medical problems and require frequent doctor’s visits. These patients would be 
considered to have poor prognoses. On the other hand, there are those who make frequent 
doctor’s visits because they can afford the care and want to ensure that they are healthy. 
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These patients could be considered to have good prognoses. It is unclear from our data 
whether these frequent ambulatory care visits were from either or both of these groups.  
Another contributing reason for insignificant relationship between ambulatory 
care utilization and AMI outcome may arise from how some cardiac comorbidities are 
managed. Cardiac comorbidities such as atrial fibrillation and chronic kidney disease may 
warrant frequent physician visits to monitor international normalized ratios (INR) 
associated with warfarin therapy, and to receive dialysis. In our study, I found that those 
with these conditions were associated with increased ambulatory care utilization. Also, 
diseases such as congestive heart failure and diabetes are nowadays closely monitored 
and being used to measure the quality of patient care. This may prompt healthcare 
providers to allow more frequent ambulatory clinic visits. Although these cardiac 
comorbidities may increase cardiovascular risks, the way these medical conditions are 
being managed can improve AMI outcomes from close medical management. 
The most interesting finding of the study is minorities having decreased odds of 
being hospitalized for AMI. This observation is significant. First, if minorities are less 
likely to be admitted for AMI, this will result in a smaller denominator when calculating 
their inpatient mortality. If there is similar population-level mortality, but fewer 
minorities die in the community from AMI, the measured inpatient AMI mortality may 
appear to be higher. Second, there may be a selection bias in AMI admission, with 
hospitals having higher thresholds to admit minorities with cardiac symptoms. From our 
study, it is unclear whether this selection bias is coming from a belief that Asians are 
perceived to have less severe disease or whether they are less likely to have health 
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insurance. Thus, minorities who are admitted with AMI may be the ones with more 
severe diseases, and with worse health outcomes. I addressed this limitation to some 
degree by adjusting for comorbidities, using the Elixhauser index. Lastly, the finding may 
be due to cultural differences, including trust towards healthcare systems and religious 
beliefs. These characteristics, at the individual level, can affects patients’ decisions to go 
to the Emergency Room and then be hospitalized for AMI.  
Besides ambulatory care utilization, there are other factors that could contribute to 
the high inpatient AMI mortality among Asian Americans. Asians encompass a diverse 
population and studies have identified heterogeneity in cardiovascular disease risk factors 
among Asians by country of origin. For example, previous studies have identified that 
South Asians have more cardiovascular risk factors and worse outcomes compared to 
Whites72-74. In addition, studies have found that certain Asian and Hispanic ethnic groups 
have significantly lower insurance rates75 and it is possible that these small groups of 
Asians with disadvantaged socioeconomic factors may have a significant impact on 
overall AMI mortality. Lastly, the presence of communication barriers among Asians 
with limited English proficiency could contribute to poor health outcomes76-78, and 
possibly higher AMI mortality. 
There are several limitations with the study. I do not have clinical information 
regarding decisions behind why patients received cardiac procedures but the high cardiac 
procedure rate among Asians might be due to more advanced or severe cases that require 
invasive interventions. The higher mortality among those receiving cardiac procedures 
needs further examination, as identifying contributing factors can improve future 
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outcomes. If the high mortality is due to a high comorbidity burden, future studies should 
focus on re-stratifying risk for all AMI patients. However, if the high mortality is coming 
from procedure-related complications common among Asians, such as high bleeding risk 
after anti-platelet therapy79-81, then different medical therapies, such as lower doses of 
antithrombotic medications, should be used. Also, Asians with AMI may seek medical 
care when cardiac symptoms are severe and have been present for longer durations. 
Delays in receiving care have been associated with poor outcomes82-84. In a study that 
examined patients with symptoms present less than 24 hours, there was no difference in 
mortality between Asians and non-Hispanic Whites85. Our study did not differentiate 
patients based on their duration of symptoms, and the high mortality could have 
originated from higher inpatient mortality among Asians with longer duration of 
symptoms. 
Other limitations arise from study design and the nature of the data. Given our 
observational data, a causal relationship cannot be established between being Asian and 
increased inpatient AMI mortality. Due to the nature of secondary, administrative data, 
information on clinical patient status is limited. For example, clinical information 
regarding duration or severity of symptoms, admission vitals, EKG findings, and 
procedure complications could have provided further insight. The data also did not 
include medications, which would have been helpful in understanding race/ethnicity-
specific medical management of AMI, and how clinical decisions were made in obtaining 
invasive cardiac procedures. Previous research has shown mixed results as to whether 
racial differences existed in decision-making involving invasive cardiac procedures14,86. 
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Another limitation of this study is the use of census data to obtain socioeconomic 
information and predictors of healthcare access (insurance and employment). Though 
commonly used, census data based on zip codes and counties have limitations in 
capturing micro-level information87,88. Lastly, there has been a significant increase in 
multiracial populations, especially Asians tied to other races or ethnicities22. For our 
study, I used self-reported race/ethnicity, which did not identify multiracial patients.  
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CONCLUSION 
Among Medicare fee-for-service enrollees, Asian Americans were found to be 
low ambulatory care utilizers, specifically of ambulatory care clinic visits. Although there 
was a significant difference in hospitalization rates for angina, an ambulatory care 
sensitive condition, the rate was very small consistently among different racial/ethnic 
groups. The low ambulatory care utilization was associated with increased risk of 
inpatient AMI mortality. With the increasing number of Asians in the US, disparities in 
cardiovascular outcomes among Asian Americans warrants further investigation. Future 
research should focus on patient-level details to better understand the heterogeneity of the 
Asian population and clinical factors associated with such disparities. This can be done 
by conducting patient focus group or individual patient interviews via qualitative studies. 
In addition, it will be important to build a cohort of patient with national origin 
information to further understand how ethnic differences contribute to cardiovascular 
outcomes.  
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